摘要
目的:了解铜绿假单胞菌的耐药性,为临床合理选择抗生素提供参考。方法:回顾性分析2010年1月-2011年12月本院临床分离的铜绿假单胞菌的分布情况及耐药性。结果:共分离出铜绿假单胞菌213株,其中痰标本中分离出铜绿假单胞菌最多,占86.9%;ICU、脑外科、呼吸内科分离的菌株数居前3位;铜绿假单胞菌对阿米卡星的敏感性较高,耐药率为11.7%,对庆大霉素和妥布霉素这类氨基糖苷类抗菌药物敏感性均较好,哌拉西林/舒巴坦对铜绿假单胞菌具有较好的抗菌活性,耐药率为19.7%。结论:铜绿假单胞菌对抗菌药物的耐药性呈上升趋势,加强医院感染病原菌的耐药性监测,对合理使用抗菌药物及减缓多药耐药菌的产生尤为重要。
Objective:To investigate the distribution and drug resistance of Pseudomonas aeruginosa separated in hospital,and to provide clinicians the laboratory evidence for guiding antibiotic therapy.Methods: The clinical distribution and the susceptibility test results of Pseudomonas aeruginosa isolated from our hospital from January,2010 to December,2011 were analyzed retrospectively.Results: Among 213 clinical isolates of Pseudomonas aeruginosa,the isolation rate from sputum was the highest(86.9%).The isolates were mainly found in ICU,department of brain surgery and respiration department.They were highly resistant to cefoperazone/sulbactam(19.7%),aminoglycosides: amikacin(11.7%),gentamicin,tobramycin.Conclusion: The resistant rate of Pseudomonas aeruginosa is increasing year by year.Therefore,monitoring bacterial drug resistance is very important for the rational use of antibiotics and slowing the development of multi-drug bacteria.
出处
《中国卫生检验杂志》
北大核心
2012年第11期2777-2779,共3页
Chinese Journal of Health Laboratory Technology
关键词
铜绿假单胞菌
耐药性
抗菌药物
Pseudomonas aeruginosa
Resistance
Antibiotics